30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Mortimer, Ian Charles

Track

Insider profile

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 93% 68% 82%
Transactions
20 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Mortimer, Ian Charles's trades of Xenon Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-16 2026-03-13
S Sale
17,588 -14.5%
490.87
US$1,145,875 		17,588 -14.5% 490.87 US$1,145,875
2026-03-13 2026-03-09
S Sale
52,136 +0.9%
171.16
US$242,688 		52,136 +0.9% 171.16 US$242,688
2026-03-13 2026-03-09
S Sale
72,858 +13.1%
363.47
CA$3,647,239 		72,858 +13.1% 363.47 CA$3,647,239
2026-03-13 2026-03-09
S Sale
43,348 -39.1%
59.26
US$2,568,802 		43,348 -39.1% 59.26 US$2,568,802
2026-03-13 2026-03-09
S Sale
2,449 -29.0%
61.26
US$150,026 		2,449 -29.0% 61.26 US$150,026
2026-03-13 2026-03-09
S Sale
10,072 -54.4%
60.47
US$609,054 		10,072 -54.4% 60.47 US$609,054
2026-03-13 2026-03-09
S Sale
12,479 -40.3%
59.50
US$742,500 		12,479 -40.3% 59.50 US$742,500
2026-03-13 2026-03-09
S Sale
21,515 -78.2%
60.49
US$1,301,442 		21,515 -78.2% 60.49 US$1,301,442
2026-03-13 2026-03-09
S Sale
31,694 -53.5%
59.88
US$1,897,837 		31,694 -53.5% 59.88 US$1,897,837
2026-03-13 2026-03-09
S Sale
21,791 -26.9%
58.81
US$1,281,529 		21,791 -26.9% 58.81 US$1,281,529
2026-01-06 2026-01-02
S Sale
2,062 -25.6%
44.93
US$92,646 		2,062 -25.6% 44.93 US$92,646
2026-01-06 2026-01-02
S Sale
37,938 -82.5%
44.40
US$1,684,447 		37,938 -82.5% 44.40 US$1,684,447
2025-12-10 2025-12-08
S Sale
2,010 -25.1%
46.32
CA$93,103 		2,010 -25.1% 46.32 CA$93,103
2025-12-10 2025-12-08
S Sale
8,820 -52.4%
45.59
CA$402,104 		8,820 -52.4% 45.59 CA$402,104
2025-12-10 2025-12-05
S Sale
14,375 -46.1%
45.03
CA$647,306 		14,375 -46.1% 45.03 CA$647,306
2025-12-04 2025-11-28
S Sale
97 -0.3%
45.01
US$4,366 		97 -0.3% 45.01 US$4,366
2025-10-02 2025-10-01
S Sale
25,000 -44.4%
40.16
US$1,004,000 		25,000 -44.4% 40.16 US$1,004,000
2025-01-28 2025-01-27
S Sale
1,149 -3.5%
41.07
US$47,189 		1,149 -3.5% 41.07 US$47,189
2025-01-28 2025-01-27
S Sale
15,166 -32.6%
40.46
US$613,616 		15,166 -32.6% 40.46 US$613,616
2025-01-28 2025-01-24
S Sale
22,468 -41.8%
40.20
US$903,214 		22,468 -41.8% 40.20 US$903,214
2025-01-28 2025-01-23
S Sale
16,217 -34.1%
40.08
US$649,977 		16,217 -34.1% 40.08 US$649,977
2024-10-02 2024-09-27
B Purchase
200,000 +176.5%
0.42
CA$84,000 		200,000 +176.5% 0.42 CA$84,000
2023-05-26 2023-05-24
S Sale
1,407 -4.3%
41.49
US$58,376 		1,407 -4.3% 41.49 US$58,376
2023-05-26 2023-05-24
S Sale
13,179 -32.2%
41.37
US$545,215 		13,179 -32.2% 41.37 US$545,215
2023-05-26 2023-05-24
S Sale
17,069 -41.3%
41.44
US$707,339 		17,069 -41.3% 41.44 US$707,339